About This Trial
This randomized, controlled, open-label study is designed to evaluate the efficacy and safety of differing durations of IV treatment, given in the hospital or at home for a pulmonary exacerbation in adult patients with CF.
- Status: Enrolling now
- Location: Miami Valley Hospital
- Study type: Interventional
- Ages eligible for study: 18 and older
- Genders eligible for study: Both
- Principal Investigator: Hari, Polenakovik, MD
- For more information about this study, visit ClinicalTrials.gov: NCT02781610
Contact Us
If you would like information about participating in this study, contact:
Linda Clark
937-208-2913
lclark@premierhealth.com